title: Outlook in oral and cutaneous Kaposi's sarcoma.
abstract: We looked at survival of 138 patients with HIV-1-associated Kaposi's sarcoma. Patients with lesions of the oral mucosa had a higher death rate (risk ratio 3.4 [95% CI 1.6-7.1]; p=0.001) than those having exclusively cutaneous manifestations of the disease. Patients with oral Kaposi's sarcoma and a CD4 cell count of at least 150/microL had a similar mortality risk to patients with the cutaneous disease but CD4 cell concentration of no more than 150/microL. Thus, oral Kaposi's sarcoma is an important prognostic marker, at least for patients who do not receive triple antiretroviral therapy.
authors.forename: B
authors.initials: B
authors.lastname: Rohrmus
authors.forename: E M
authors.initials: EM
authors.lastname: Thoma-Greber
authors.forename: J R
authors.initials: JR
authors.lastname: Bogner
authors.forename: M
authors.initials: M
authors.lastname: Röcken
mesh_terms: D005858:Germany / Q000453:epidemiology; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D009062:Mouth Neoplasms / Q000401:mortality* / Q000821:virology; D012514:Sarcoma, Kaposi / Q000401:mortality* / Q000821:virology; D012878:Skin Neoplasms / Q000401:mortality* / Q000821:virology; D016019:Survival Analysis